Jana Podzimek, DO
Plastic Surgery within the Head & Neck · Auburn, NYNPI 1356314058
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,760 of the $2,798 with a category attached, or 62.9%. Medical Device Business Services, Inc. accounts for 65.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $2,120 and has fallen 96.8% since, to $67 in 2024.
Across 49 payments — averaging $57.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$2K
- Acclarent, Inc$181
- Intersect ENT, Inc.$108
- Stryker$102
- AstraZeneca$93
- Bayer$82
- plus $410 from 10 others
What the payments were for
- Travel & lodging$1,76063%
- Food & beverage$96735%
- Education$662%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 7 | $1,823 |
| Acclarent, Inc | 7 | $181 |
| Intersect ENT, Inc. | 4 | $108 |
| Stryker | 2 | $102 |
| AstraZeneca | 5 | $93 |
| Bayer | 4 | $82 |
| OPKO Pharmaceuticals, LLC | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Calliditas Therapeutics US Inc. | 3 | $56 |
| Aerin Medical Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Integra Lifesciences Corporation | 1 | $42 |
| Sanofi | 2 | $42 |
| Fresenius USA Marketing, Inc. | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $18 |
| Optinose US, Inc. | 1 | $16 |
How this compares
$2,798 in reported general payments places this provider in the 75th percentile of 45 plastic surgery within the head & neck providers in New York.
See all plastic surgery within the head & neck providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 90 | $3,688 |
| Ipratropium Bromide | 46 | $1,868 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 20 | $1,766 |
| Fluticasone Propionate | 84 | $1,247 |
| Mometasone Furoate | 30 | $1,153 |
| Montelukast Sodium | 68 | $745 |
| Levocetirizine Dihydrochloride | 43 | $451 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $219 |
| Pantoprazole Sodium | 11 | $146 |
| Famotidine | 11 | $65 |
| Omeprazole | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery within the head & neck in Auburn
- Robert SchwarczNew York$188K
- James MarottaSmithtown$69K
- Roger KatzSyosset$28K
- Robert LohmanBuffalo$21K
- William BellesTonawanda$15K
- Eric CohenNew York$9K
- Anthony AlessiValhalla$7K
- Erich VoigtNew York$6K
- George BraunNew York$4K
- Adrian OngNew York$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.